Lessons learned from genetic testing.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Awareness, Perceptions, and Provider Recommendation Related to Genetic Testing for Hereditary Breast Cancer Risk among At-Risk Hispanic Women: Similarities and Variations by Sub-Ethnicity.

Expanding the Criteria for BRCA Mutation Testing in Breast Cancer Survivors.

Communication of BRCA Results and Family Testing in 1,103 High-Risk Women.

Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.

BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.

The double-helix derailed: the story of the BRCA patent.

Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis.

Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients.

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families.

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.

Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers]

Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.

Genetic/familial high-risk assessment: breast and ovarian.

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.

Pre-counseling Education for Low Literacy Women at Risk of Hereditary Breast and Ovarian Cancer (HBOC): Patient Experiences Using the Cancer Risk Education Intervention Tool (CREdIT).

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer]

Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.

The virtual consultation: practitioners' experiences of genetic counseling by videoconferencing in Australia.

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.

Further development and evaluation of a breast/ovarian cancer genetics referral screening tool.

BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia.